NUVB
Nuvation Bio Inc.
+0.34 (+5.97%)6.13USD2.5M成交股數2.2B市值–本益比(近四季)12.7股價營收比+555.6%營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 31.7M+927% | 83.2M+1357% | 13.1M+1705% | 4.8M+237% | 3.1M | 5.7M | 727K | 1.4M | 0.00 | 0.00 | 0.00 | – |
| 營業成本 | – | – | 3.3M | 2.6M | 2.1M | 4.2M | 1.5M | 1.3M | 0.00 | – | – | – |
| 毛利 | – | – | 9.8M-1340% | 2.3M+2465% | 990K | 1.5M | −788K | 88K | 0.00 | 0.00 | 0.00 | – |
| 毛利率 | – | – | 74.5% | 46.7% | 32.1% | 26.2% | -108.4% | 6.1% | – | – | – | – |
| 研發費用 | 30.7M | 35.0M | 28.8M | 27.4M | 24.6M | 29.3M | 27.7M | 29.2M | 12.8M | 18.6M | 18.6M | 18.8M |
| 銷售管理費用 | 42.6M | 38.3M | 37.4M | 38.5M | 35.4M | 26.1M | 19.6M | 16.2M | 7.4M | 7.8M | 7.5M | 7.7M |
| 營業利益 | −51.0M-14% | 3.9M-107% | −56.4M+17% | −63.6M-86% | −59.0M+192% | −53.9M+105% | −48.1M+84% | −470M+1674% | −20.2M | −26.3M | −26.1M | −26.5M |
| 營業利益率 | -161.1% | 4.7% | -430.1% | -1,315.7% | -1,913.2% | -944.5% | -6,616.4% | -32,779.4% | – | – | – | – |
| 稅後淨利 | −62.8M+18% | 5.4M-111% | −55.8M+35% | −59.0M-87% | −53.2M+260% | −49.4M+152% | −41.2M+100% | −462M+2029% | −14.8M | −19.6M | −20.6M | −21.7M |
| 淨利率 | -198.3% | 6.5% | -425.2% | -1,220.9% | -1,726.2% | -865.8% | -5,668.5% | -32,229.4% | – | – | – | – |
| 稀釋 EPS | -0.18+13% | 0.01 | -0.16+7% | -0.17-91% | -0.16+129% | 0.00-100% | -0.15+67% | -1.89+1790% | -0.07 | -0.09 | -0.09 | -0.10 |
| 稀釋股數 | 349K | 378K | 342K | 341K | 339K | 269K | 274K | 245K | 219K | 219K | 219K | 219K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 259M | 125M | 98.9M | 248M | 48.0M | 35.7M | 30.0M | 34.3M | 34.5M | 24.4M | 50.1M | 30.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 19.9M | 15.8M | 5.7M | 552K | 14K | 0.00 | – | – | – | – | – | – |
| 總資產 | 745M | 610M | 602M | 647M | 492M | 541M | 572M | 595M | 613M | 631M | 641M | 657M |
| 有息負債 | 243M | 47.3M | 47.1M | 47.0M | – | – | – | – | – | – | – | – |
| 總負債 | 491M | 291M | 276M | 274M | 73.0M | 76.8M | 68.9M | 62.7M | 19.1M | 19.3M | 16.8M | 16.0M |
| 股東權益 | 254M | 320M | 326M | 373M | 419M | 464M | 503M | 257M | 594M | 612M | 625M | 641M |
| 負債比 | 65.9% | 47.6% | 45.8% | 42.4% | 14.8% | 14.2% | 12.0% | 10.5% | 3.1% | 3.1% | 2.6% | 2.4% |
| 淨現金(現金 − 有息負債) | 16.0M | 78.1M | 51.8M | 201M | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 5.1M | – | – | −42.6M+171% | – | – | – | −15.7M | – | – | −19.3M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 536K | – | – | 310K | – | – | – | 58K | – | – | 56K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 87.6M
| License | 38.2M | 43.7% | +385.7% |
|---|---|---|---|
| Product Revenue | 24.7M | 28.2% | – |
| 產品 | 24.7M | 28.2% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 62.9M | +699.0% | −205M | -325.3% | -0.60 | −181M |
| FY2024 | 7.9M | – | −568M | -7,213.8% | -2.11 | −130M |
| FY2023 | 0.00 | – | −75.8M | –% | -0.35 | – |
| FY2022 | – | – | −104M | –% | -0.48 | – |
| FY2021 | – | – | −86.8M | –% | -0.44 | – |
| FY2020 | – | – | −41.7M | –% | -0.43 | – |